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Macrophages are central to both innate and adaptive immunity. With few exceptions, 
macrophages are the first cells that sense trouble and respond to disturbances in almost 
all tissues and organs. They sense their environment, inhibit or kill pathogens, take 
up apoptotic and necrotic cells, heal tissue damage, and present antigens to T cells. 
Although the origins (yolk sac versus monocyte-derived) and phenotypes (functions, gene 
expression profiles, surface markers) of macrophages vary between tissues, they have 
many receptors in common that are specific to one or a few molecular species. Here, 
we review the expression and function of almost 200 key macrophage receptors that 
help the macrophages sense what is going on, including pathogen-derived molecules, 
the state of the surrounding tissue cells, apoptotic and necrotic cell death, antibodies 
and immune complexes, altered self molecules, extracellular matrix components, and 
cytokines, including chemokines.
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iNTRODUCTiON
Macrophages are central to proper functioning of the immune system (1–4). Resting tissue mac-
rophages make ornithine (by arginase) and promote repair, called the M2 phenotype (1, 5). Tissue 
macrophages arise from embryonic precursors and from blood monocytes at varying proportions 
(6). At the extremes are microglia cells, which are entirely embryonic-derived (7) and intestinal mac-
rophages, which are entirely monocyte-derived (8) with other organs being populated by mixtures 
of both. When these tissue macrophages sense trouble (1), they express IL12 and iNOS, and become 
M1 macrophages (5). Macrophages express hundreds of sensor molecules to identify their surround-
ings (cells, extracellular matrix, and tissue), the state of the tissue (normal and healthy, apoptotic, 
ischemic, necrotic, altered, or otherwise distressed), metabolites [oxygen, pH, lactic acid, glucose, 
free fatty acids, sphingosine-1-phosphate (S1P)], lipoproteins (LDL, HDL, and their derivatives), 
antibodies (IgG, immune complexes), complement (C3a, C3bi, C5a), cytokines (IFN-γ, IL4, IL17), 
and pathogens (bacteria, viruses, fungi, parasites, and their products). Dendritic cells, another key 
sensor of pathogens, act in concert with the macrophages in initiating an adaptive immune response. 
Dendritic cells activate the adaptive immune system by antigen presentation to naive T cells in the 
context of co-activating receptors. These T cells become licensed to traffic to the infected or inflamed 
tissue (9, 10), where they see antigen presented by macrophages (11) and differentiate (CD4: Th1, 
Th2, Th17, Treg, TFH and others, CD8: CTL and others). Many products of the adaptive immune 
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system, such as cytokines, can further activate macrophages and 
alter their  function; for example, IFN-γ enhances M1 polarization 
(12) and IL4 induces alternative activation (13), thus enhancing 
M2 polarization (1, 14).
This review is focused on the inputs to the macrophage and 
dendritic cell system: the cell surface and intracellular receptors 
by which these cells sense what is going on. For details of the 
signaling networks and effector systems downstream of these 
receptors, like TRAFs (15–17), NFkB (18, 19), or inflammasome 
assembly (20), the reader is referred to other reviews. Although 
there are human homologs for almost all receptors discussed here, 
this review is entirely based on mouse data. The innate immune 
system and macrophages in particular are under enormous 
evolutionary pressure shaped by the environment and infectious 
organisms that differ between mice and humans.
TiSSUe iNPUT AT STeADY STATe
At steady state, signals from host tissue cells result in tissue-
specific gene expression profiles (21). Langerhans cells of the 
skin, alveolar macrophages, Kupffer cells of the liver, microglia 
cells of the CNS, osteoclasts, dendritic cells of the thymus, 
and other lymphoid organs all have specialized functions and 
phenotypes. This suggests that tissue-derived signals control 
the development and polarization of tissue-specific macrophage 
phenotypes. The first tissue cues were identified in osteoclasts 
(22) and peritoneal macrophages (23, 24). A key inducer of the 
peritoneal macrophage phenotype is retinoic acid produced 
by intestinal cells, which is recognized by the nuclear receptor 
retinoic acid receptor-β (RAR-β). Retinoic acid induces the 
transcription factor GATA6, which in turn controls a number 
of effector molecules (23, 24). Interestingly, RAR-β ligation also 
induces arginase-1, the defining enzyme of M2 macrophages, 
underscoring that resting peritoneal macrophages, like 
macrophages in other tissues, are in the default “healing” M2 
state. A second known M2-polarizing stimulus is lactic acid, 
produced by hypoxic cells in cancer (25). This is consistent with 
the known M2 phenotype of myeloid-derived suppressor cells 
(26), a macrophage type found in cancers. Under homeostatic 
conditions, M2 polarization is maintained by TGF-β, and TGF-β 
receptor-1 seems to be the major factor in determining microglia 
phenotype (27). Under inflammatory conditions, TGF-β induces 
a state of deactivation that is different from M2, and promotes 
the resolution of inflammation. TGF-β2 is produced by resident 
peritoneal macrophages (28) and might play a significant role in 
homeostatic maintenance of surrounding tissues.
To provide a first glimpse at the expression of almost 200 
“input” receptors, we compiled heat maps from published 
data sets on mouse peritoneal macrophages (large, small, and 
thioglycollate-elicited), microglia (27) (data set GSE62826), and 
the macrophages from lung, liver, spleen, intestinal, adipose tis-
sue, and bone marrow (23) (data sets GSE56682, 56683, 56684) 
and (29) (data set GSE47049). The transcriptome data sets were 
accessed through the Gene Expression Omnibus site1 to examine 
1 http://www.ncbi.nlm.nih.gov/geo/
the gene expression profiles in tissue-specific macrophages for 
12 categories of receptors [apoptotic cell receptors, complement 
receptors, toll-like receptors (TLR), NOD-like receptors (NLR), 
RNA and DNA receptors, C-type lectins, scavenger receptors, 
selected cytokine receptors, TNF receptor superfamily members, 
Fc receptors, selected G-protein-coupled receptors, and integrins]. 
Cross-platform comparison of gene expression profiles between 
microarray (GSE47049, GSE56682, GSE56683, and GSE56684) 
and RNA-Seq (GSE62826) was done on normalized data pro-
vided by the authors on the GEO site. The normalized values 
from different platforms were scaled by log2 transformation for 
comparison through generation of heat maps (30–32). In brief, 
MAS5.0 (Affymetrix) and quantile normalized (Illumina GUI) 
probe data available for the microarray platforms, i.e., GSE47049 
and GSE56682/83/84 from Affymetrix Mouse Genome 430 2.0 
Array and Illumina mouse expression bead chip, respectively, 
were annotated by R/Bioconductor packages2 and annotation 
files downloaded from the GEO site (GPL6105 and GPL6887). 
The normalized RPKM gene expression levels from the Illumina 
RNA-sequencing (Illumina HiSeq 2000) dataset (GSE62826) were 
obtained from the GEO site. Whenever a gene was represented 
by more than one probe set or entry, the average of the pooled 
expression values was used. Furthermore, the average value of 
the genes across the samples for a tissue from different datasets 
was calculated for log2 transformation. Cluster 3.0 with pair-wise 
complete linkage was used to perform the hierarchical analysis 
of log2 transformed expression values of around 200 genes using 
mean-centered gene expression vectors and visualized with the 
Java TreeView 10.6 (32, 33). The graphical representation of output 
as heat maps is presented in color scale from green to red (Z-score 
transformation), where red and green indicate higher and lower 
expression levels, respectively (Figure 1). Non-expressed genes 
are shown in light gray.
ReCePTORS FOR APOPTOTiC CeLLS
In many tissues, there is continuous turnover of cells, where the 
majority of them die by the process of caspase-dependent apopto-
sis. When cells undergo apoptosis, their corpses are phagocytosed 
by macrophages in a process referred to as efferocytosis (34–36). 
In addition to macrophages, epithelial cells and fibroblasts 
clear apoptotic cells. Apoptotic cells expose phosphatidylserine 
(PtdSer) on the outer leaflet of their plasma membrane, which 
serves as a recognition signal (Eat-me). Apoptotic cells, at the 
earliest stages of death, also release ATP and other molecules that 
serve as diffusible “find-me” signals to attract macrophages to 
their proximity. The find-me signals are sensed by tissue-resident 
macrophages via some G-protein-coupled receptors, such as 
P2Y2 sensing ATP and UTP released from apoptotic cells, and 
CX3CR1 sensing CX3CL1 released from apoptotic cells.
There are several recognition systems for PtdSer (Table  1). 
Routine, homeostatic uptake of apoptotic cells is inherently 
anti-inflammatory and helps keep the local tissue inflammation 
to a very minimal (or below detection) level even in tissues 
2 http://www.r-project.org
FiGURe 1 | Gene expression in resident tissue-specific macrophages (microglia, lung, liver, spleen, intestinal, adipose) and bone marrow-derived 
macrophages (BMDM) for comparison. 
(Continued)
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where there is a very high cell turnover (such as the bone mar-
row or thymus). This is in part achieved through the release of 
mediators, such as TGF-β, IL10, and prostaglandin E2 (PGE2) 
from macrophages that engage apoptotic cells. TGF-β and IL10 
have anti-inflammatory functions. Depending on the receptor 
triggered (EP1-EP4), PGE2 can have pro- and anti-inflammatory 
functions, modulate pain sensation, and can activate mast cells 
(37). See Ref. (38, 39) for more details on apoptotic cell clearance. 
αVβ3 integrin (see Integrins) recognizes PtdSer through MFGE8. 
RAGE and stabilin 2 also bind PtdSer and are listed under scaven-
ger receptors (below). Tyro3, Axl, and Mer bind PtdSer through 
GAS6 (gene name Gas6) or protein S (gene name Pros1). Mertk, the 
gene encoding Mer tyrosine kinase, distinguishes macrophages 
from dendritic cells and has been proposed as a universal mouse 
macrophage marker (40) when used in combination with other 
markers like F4/80, CD68, or CD11b. CD91, also known as LDL 
receptor-related protein LRP, is a receptor for calreticulin, which 
is exposed in cells undergoing ER stress and apoptosis. SIRPα 
(gene name Sirpa) can detect CD47 on apoptotic lymphocytes. 
The results presented in Figure  1A summarize the expression 
of genes related to apoptotic cell recognition and uptake. The 
clearance of apoptotic cells by phagocytes is counterbalanced by 
mechanisms that limit detrimental effects, such as production of 
reactive oxygen species. Also, efferocytic receptors, such as Mer 
and CD11b, can be downregulated, a process that limits further 
signaling and uptake of apoptotic cells.
FiGURe 1 | Continued 
Heat maps based on hierarchical clustering results from microarray and RNA-Seq data for (A) apoptosis receptors, (B) complement receptors, (C) toll-like 
receptors, (D) NOD-like receptors, (e) RNA and DNA sensors, (F) C-type lectins, (G) scavenger receptors, (H) integrins, (i) tumor necrosis factor receptor 
superfamily, (J) Fc receptors, (K) G-protein-coupled receptors, and (L) cytokine receptors. Gene expression levels are expressed in log2 values, differences shown 
in color scale after Z-score transformation. Colors scale bar ranges from red (+3) to green (−3). Light gray indicates undetectable.
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TABLe 1 | PtdSer recognition receptors.
Gene 
name
PtdSer 
receptors
Function PtdSer binding
Bai1 BAI1 Upstream of ELMO1-DOCK180-RAC, 
engulfment
Direct PtdSer 
binding
Havcr1 TIM1 Also hepatitis A virus receptor Direct PtdSer 
binding by metal 
ion-dependent 
binding site
Havcr2 TIM3 Also for antigen cross-presentation
Timd4 TIM4 Only tethering of apoptotic cells  
without direct signaling to engulfment
Tyro3 Tyro3 Tyrosine kinase receptor Indirect PtdSer 
binding through 
Gas6 or protein S
Axl Axl Tyrosine kinase receptor
Mertk Mer Tyrosine kinase receptor, universal 
mouse macrophage marker
ReCePTORS FOR NeCROTiC CeLLS AND 
MODiFieD SeLF
Macrophages sense when tissue cells are distressed by events, 
such as ischemia (pro-angiogenic, pro-inflammatory), reperfu-
sion (pro-inflammatory), tissue necrosis (pro-inflammatory), 
and altered self induced by enzymatic modification resulting in 
(lipo) protein citrullination (41), oxidation (42), or nitrosyla-
tion (43). Many of the receptors for altered self are among the 
category of cell surface molecules that are generally referred to as 
scavenger receptors (see below). Macrophages express many 
scavenger receptors that are capable of recognizing these necrotic 
or altered self-molecule on stressed cells within tissues.
Necrotic cells are opsonized by complement factors that are 
recognized through complement receptors (44, 45) (Table  2; 
expression in Figure  1B). The scavenger receptor RAGE 
(see below) also recognizes apoptotic cells and triggers pro-
inflammatory mechanisms. The IL33 receptor ST2 detects IL33 
released by necrotic cells. CD24 on macrophages binds HMGB1, 
which in turn binds necrotic cells. Mincle (Clec4e) and CLEC9A 
are two C-type lectins (listed below) involved in the uptake of 
necrotic cells. TLRs (see below) can recognize the nuclear protein 
HMGB1, the Sin3A-Associated Protein SAP130, the heat shock 
protein HSP90, DNA, and urate crystals, all of which can be 
exposed on or released from necrotic cells.
PATHOGeN ReCePTORS
Pathogen sensors on macrophages can detect bacterial, viral, 
fungal, and parasite infections. These receptors bind pathogens 
directly or recognize their products. They form six main classes: 
TLR (17, 46), NLR (20, 47), receptors for intracellular RNA, 
including RIG-I like receptors (RLR) (48), receptors for intracel-
lular DNA, including STING (49, 50), C-type lectins (51, 52), and 
scavenger receptors (53).
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TOLL-LiKe ReCePTORS
Toll-like receptors (Table 3) are a family of homodimeric trans-
membrane receptors that recognize bacterial, viral, and fungal 
products. Some also have endogenous ligands. TLRs 1, 2, 4, 5, 
and 6 are expressed on the plasma membrane, whereas TLRs 
3, 7, 8, and 9 are expressed in endosomes (17, 54). Most TLRs 
signal through the MyD88 pathway, ultimately resulting in NFkB 
activation, except TLR3, which signals through the intermedi-
ary TRIF resulting in type I interferon production. TLR4 signals 
through both MyD88 and TRIF. (Note: TLR10 is not expressed 
in mice).
The intracellular vesicles in which TLR3, 7, 8, and 9 are 
expressed include ER, endosomes, lysosomes, and endolys-
osomes. An excellent review of TLR expression and function is 
found in Ref. (17). The results presented in Figure 1C indicate the 
expression levels of TLRs in various tissue macrophages.
NOD-LiKe ReCePTORS OR NBD–LRR 
CONTAiNiNG PROTeiNS
This class of pathogen receptors/sensors (20) regulates a number 
of key inflammatory pathways. NLRs (Table 4) contain a nucle-
otide-binding domain (NBD) and leucine-rich repeats (LRR). 
These proteins are conserved in evolution from plants to humans. 
NLR proteins are subdivided by their N-terminus, which can con-
tain acid transactivation, pyrin, CARD, or BIR domains. A major 
pathway is the activation of the inflammasome, which is a macro-
molecular structure that when assembled, causes the cleavage and 
activation of caspase-1, and thus can produce the active species of 
IL1β and IL18. There are 22 known human NLRs; here, only the 
best-studied will be discussed. Some, but not all NLRs assemble 
an inflammasome. Additionally, some inflammasome-inducing 
NLRs also exhibit inflammasome-independent functions. The 
molecular mechanisms of inflammasome activation have been 
reviewed elsewhere (20). This review will briefly describe the key 
NLR molecules important for macrophage sensing with a focus 
on the inflammasomes.
The best-studied inflammasome is anchored by NLRP3, a 
receptor that does not directly recognize DAMPs or PAMPs but 
rather responds to cellular stress, including changes in potassium 
efflux, ROS production, ER stress, and unfolded protein response. 
The adapter GBP5 promotes NLRP3 inflammasome activation 
by ATP, nigericin, and bacteria, but not by crystalline agents. 
Several inhibitory pathways for NLRP3 activation have also been 
described. For example, nitric oxide can cause the S-nitrosylation 
TABLe 2 | Complement receptors.
Gene 
name
Complement 
receptors
CD  
name
Function
Cr1 CR1 CD35 Binds C3b and C4b, processes opsonized 
particles
Cr2 CR2 CD21 Binds C3bi, C3d. In the mouse, both CR1 
and CR2 are derived from the  
Cr2 locus by alternative splicing (44)
Itgam
Itgb2
CR3 CD11b/
CD18
Obligatory heterodimer, binds C3bi, 
denatured proteins  
(and many other ligands)
Itgax
Itgb2
CR4 CD11c/
CD18
Obligatory heterodimer, binds C3bi, 
denatured proteins
C3ar1 C3aR Binds C3a
C5ar1 C5aR1 CD88 Binds C5a, activates macrophages
C5ar2 C5aR2 Binds C3a, C5a, and their desarginated 
inactive forms
Cd59a CD59 CD59 Inhibits the membrane attack complex
Cd46 MCP CD46 CD46 and CD55 inactivate the C3/C5 
cleaving enzymesCd55 Decay-accelerating 
factor DAF
CD55
TABLe 3 | Toll-like receptors.
Gene 
name
TLR Ligands Location and function Dimerization
Tlr1 TLR1 Bacterial lipoproteins Cell surface. Activates NFkB through TIRAP, MyD88, IRAKs, 
TRAF6
Heterodimerizes with TLR2
Tlr2 TLR2 Lipoproteins, LTA, PGN, lipoarabinomannan, 
viral proteins, fungal mannans, trypanosome 
tGPI–mutin
Cell surface. Activates NFkB through TIRAP, MyD88, IRAKs, and 
TRAF6
Heterodimerizes with TLR1 
or 6 or CD36, homodimer in 
endosomes
Tlr3 TLR3 Viral RNA Intracellular vesicles, activates NFkB through TRIF-TAK1 and type 
I interferons through TRIF-TRAF3
Homodimer in endosomes
Tlr4 TLR4 LPS, fungal mannans, glycoinositol-
phospholipids of parasites, oxLDL
Cell surface and phagosomes, activates NFkB through TIRAP, 
MyD88, IRAKs, and TRAF6, and induces type 1 interferons 
through TRAM-TRIF-IRF3
Homodimer
Tlr5 TLR5 Flagellin Cell surface. Activates NFkB through MyD88, IRAKs, TRAF6 Homodimer
Tlr6 TLR6 TLR2/6: bacterial lipoproteins, fungal 
zymosan, β-glucan
Cell surface. Activates NFkB through TIRAP, MyD88, IRAKs, 
TRAF6
Heterodimerizes with TLR2
Tlr7 TLR7 Bacterial, viral, and fungal RNA Intracellular vesicles, activates NFkB through MyD88, TRAF6, 
induces type I interferons via MyD88
Homodimer in endosomes
Tlr8 TLR8 Viral RNA Intracellular vesicles
Tlr9 TLR9 Bacterial, viral, fungal, and parasite DNA Intracellular vesicles, activates NFkB through MyD88, TRAF6, 
induces type I interferons via MyD88
Homodimer in endosomes
TABLe 4 | NOD-like receptors.
Gene name NLR Pathogen or disturbance Downstream effectors, function, and regulation
Nlrp3 NLRP3 Cellular stress Activates caspase-1 through ASC
ER stress
And ATP Inhibited by NO from iNOS (S-nitrosylation)
Monosodium urate, alum
Nlrc4 NLRC4 Bacterial type III (T3SS) and IV (T4SS) 
secretion system, cytosolic flagellin
Activates caspase-1 to activate IL-1 and IL-18, blocks STING pathway
Nlrc3 NLRC3 HSV Blocks STING pathway
Nlrp1a NLRP1A Lethal toxin (LT) of Bacillus anthracis (mouse)
Muramyl dipeptide (MDP) and titanium 
dioxide (human)
Nlrp1b NLRP1B
Nlrp1c NLRP1C
Nlrp6 NLRP6 [PYPAF5] Pathobiont bacteria, Bacteroidetes 
(Prevotellaceae), and TM7 microbiota
Blocks NFkB and MAPK pathway, activates caspase-1, inflammasome
Nlrp7 NLRP7 Mycoplasma acylated lipopeptide (acLP) Inflammasome: hydatidiform
Nlrp12 NLRP12 Yersinia, malaria Inflammasome function, inhibits NFkB and MAPK
Nlrc5 NLRC5 Bacteria, PAMPs, DAMPs, rhinovirus Inflammasome function
MHC class I gene expression
Aim2 AIM2 Cytosolic DNA Activates Caspase-1 through ASC
Pycard ASC Common adaptor for inflammasome 
activation
Activates caspase-8 and -9
Naip1 NAIP1 NAIPs provide ligand specificity to the 
NLRC4 inflammasome.
Naip1, 2, 5, and 6 provide ligand specificity to the NLRC4 inflammasome. Specifically, 
Naip1 detects the bacterial rod, and Naip5 and 6 detect bacterial flagellins (61). The 
Naips are involved in expulsion of salmonella-infected enterocytes (62).
Naip2 NAIP2
Naip4 NAIP4
Naip6 NAIP6
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of NLRP3 and impair assembly of the inflammasome (55–57). 
The G Protein signaling modulator-3 protein can associate with 
the LRR domain of NLRP3 and inhibit inflammasome activation. 
cAMP binds and inhibits NLRP3, and the neurotransmitter 
dopamine negatively regulates NLRP3 function via cAMP that 
promotes NLRP3 ubiquitination and subsequent degradation by 
the E3 ligase, MARCH7 (58). NLRP3 inflammasome activation 
depends on ASC (gene name Pycard), a common adaptor required 
for the activation of caspase-1 by several inflammasomes, and is 
comprised of a pyrin domain and a CARD domain. Linear ubiq-
uitination via the assembly complex LUBAC is known to enhance 
ASC function in the activation of NLRP3-dependent inflamma-
some (59). The NLRP3 inflammasome also senses mitochondrial 
DNA. Activated caspase-1 or the related caspase-11 can induce 
pyroptosis (lytic cell death).
The NLRC4 inflammasome activation (60) is enhanced by 
ASC, and it detects bacterial proteins in the cytosolic compart-
ment, either as markers for the activity of bacterial type III and 
IV secretion systems or cytosolic invasion by flagellated bacteria. 
NLRC4 responds to injection of three conserved bacterial pro-
teins: flagellin, rod, and needle. NAIP proteins are also members 
of the NLR family. NAIP1, 2, 5, and 6 provide ligand specificity to 
the NLRC4 inflammasome. Specifically, NAIP1 detects the bac-
terial Needle protein, NAIP2 detects bacterial Rod, and NAIP5 
and 6 detect bacterial flagellins (61). The NAIPs are involved in 
expulsion of salmonella-infected enterocytes (62).
NLRP1 (DEFCAP, NAC, or NALP1) is the NLR that defined 
the inflammasome (63). Mice express three highly polymorphic 
paralogs: Nlrp1a, Nlrp1b, and Nlrp1c due to likely gene duplica-
tion, while humans only express a single NLRP1. Mouse Nlrp1b 
and rat Nlrp1, but not human NLRP1 mediates the response to 
the lethal toxin (LT) of Bacillus anthracis. Reminiscent of the 
requirement of a cleavage/activation process for caspase-1, IL1β, 
and IL18 function, a maturation cleavage of the N-terminal of 
murine NLRP1 is also required for its activation by LT (64). 
Among pathogens, NLRP1 is also activated by Toxoplasma gondii 
and is required for host protection (65), although this process 
does not require the above-mentioned N-terminal cleavage (66). 
NLRP1 is not the only NLR required for inflammasome activa-
tion by T. gondii, as NLRP3 was also shown to play a role in host 
resistance to this pathogen (67).
NLRP6 was originally found to synergize with ASC to cause 
NFkB and caspase-1 activation in overexpression systems. Nlrp6−/− 
mice show spontaneous and induced colitis (68), associated with 
reduced IL18 and expanded pathobiont bacteria, Bacteroidetes 
(Prevotellaceae), and TM7 microbiota (69). Other reports indi-
cate alternative roles for the NLRP6 in the control of intestinal cell 
apoptosis or as a checkpoint regulator of inflammatory mediators 
and the NFkB/MAPK pathways.
Other NLRs with inflammasome functions also have demon-
strated in vitro relevance in other important pathways. For exam-
ple, NLRP7 mediates inflammasome activation by mycoplasma 
acylated lipopeptide in a human macrophage cell line, but it 
has been genetically linked in multiple patient cohorts (70) to 
the formation of hydatidiform moles, which is an abnormal 
form of pregnancy. NLRP12 (Monarch-1 or PYPAF7) exhibits at 
least two functions as an inhibitor of the non-canonical and the 
canonical NFkB pathway. This was confirmed by in vivo studies 
of colitis-associated colon carcinoma models (71, 72), a bacterial 
infection model as well as a study of osteoclasts. Yersinia strains, 
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but not several other bacteria, can cause Nlrp12-dependent 
inflammasome activation (73), and Plasmodium species induce 
a NLRP12- and NLRP3-dependent inflammasome activation 
(74). This dual requirement for two NLR is also observed with 
NLRC5 and NLRP3, which interact with each other in a human 
macrophage cell line and PBMCs in response to a host of NLRP3 
activators (75). Nlrc5−/− mice show deficiencies in response to 
NLRP3 activators, such as monosodium urate, alum, and ATP 
(76). However, the primary function of NLRC5 is the regulation 
of class I MHC genes, thus demonstrating again the multi-faceted 
nature of NLRs (77).
In addition to the activation of caspase-1, a non-canonical 
pathway leading to caspase-11 maturation that requires NLRP3, 
and can be activated by some bacteria, which appears to be 
detrimental during endotoxic shock (78). Caspase-11 is activated 
by LPS from Gram-negative bacteria that invade the cytosol, 
and protects mice against lethal infection by Burkholderia thai-
landensis and Burkholderia pseudomallei. By contrast, vacuolar 
bacteria, such as Salmonella typhimurium are poorly detected by 
caspase-11. Caspase-11 is non-responsive, unless macrophages 
are primed by IFN-β or IFN-γ, both of which activate the tran-
scription factor STAT1. Caspase-11 responds to cytosolic lipid 
A species with five or six acyl groups, but not to species with 
four acyl groups. This expands the role of LPS as a key microbial 
pattern detected by the innate immune system: extracellular and 
vacuolar LPS is detected through TLR4, whereas cytosolic LPS 
is detected through caspase-11. Interestingly, both Tlr4- and 
caspase-11-deficient mice are resistant to classical LPS challenge 
(78). The results presented in Figure  1D reveal the expression 
levels of NLR and related molecules.
SeNSORS FOR iNTRACeLLULAR  
RNA AND DNA
RNA and DNA receptors recognize components of viral 
genomes.  Herpes viruses such as herpes simplex or murine 
 cytomegalovirus (MCMV) are double-stranded (ds)DNA viruses, 
where the dsDNA is recognized by STING or IFI16 (mouse 
gene name Ifi204). Single-stranded (ss) viral RNA often forms 
stem–loop structures that can be detected by TLR7 (see Toll-Like 
Receptors) and RIG-I (79). ssDNA (not necessarily viral) is recog-
nized by TLR9, especially when it is CpG-rich and not methylated.
These receptors are expressed in macrophages, epithelial cells, 
and other cells. The immune response starts in infected cells, 
where the viruses replicate in the cytoplasm. The intracellular 
viral RNA is detected by the RIG-I family of receptors, including 
RIG-I (gene name: Ddx58), MDA5 (Ifih1), and LGP2 (Dhx58). 
RIG-I detects many ssRNA viruses, including influenza virus, 
hepatitis C, Dengue, yellow fever, west Nile, and Ebola. The RIG-I 
family receptors require MAVS as an adapter protein and IRF3 
or IRF7 as downstream transcription factors, resulting in the 
elaboration of IFN-α and β.
Single-stranded DNA is recognized by TLR9 (see Toll-Like 
Receptors). DNA-derived intracellular cyclic dinucleotides are 
recognized by STING (gene name, Tmem173) (80). Humans 
have five common STING alleles. Listeria products are processed 
by cGAS (cyclic GMP AMP synthetase), which produces cGMP 
that in turn activates STING. STING is also involved in detect-
ing herpes virus. Other sensors for intracellular DNA are DAI 
(gene name, Zbp1), Aim2 (see under NLRs), DDX41 (Ddx41), 
DHX9 (Dhx9), IFI16 (gene name, Ifi204), and DHX36 (Dhx36). 
DAI senses dsDNA. The results in Figure 1E show the mRNA 
expression of these DNA- and RNA-sensing receptors in various 
tissue-resident macrophages. Aim2 expression was only detected 
in bone marrow-derived macrophage (BMDM), peritoneal mac-
rophages, and microglia.
C-TYPe LeCTiN ReCePTORS
In general, C-type lectin receptors (Table 5) recognize multiva-
lent carbohydrate ligands (4) that might be present on endothelial 
cells, epithelial cells, pathogens, and other microorganisms. 
C-type lectins are also involved in the uptake and clearance of 
dead cells (6). Macrophages express several C-type lectin recep-
tors, which include collectins, selectins, lymphocyte lectins, and 
proteoglycans (4). Some are important sensors for fungal infec-
tions (81), others such as the selectins recognize host glycans 
(82). The C-type lectins DCIR and MICL are inhibitory, because 
their cytoplasmic tails contain ITIM domains. Dectin-2, Mincle, 
and DCAR are coupled to an ITAM-domain containing adaptor. 
Dectin-2 is the prototypic receptor of the Dectin-2 subfamily of 
C-type lectins that also contains CLECSF8, DCIR and Mincle and 
DCIR2, 3, and 4, DCAR, and DCAR1 in mice only (5). SignR3, 
Dectin-1, and CLEC9a also contain at least one ITAM domain. 
DC-Sign, SIGN-R1, Langerin, MGL, DEC-205, and the mannose 
receptor MR are not coupled to either ITAM or ITIM domains, 
but signal through adaptor proteins.
E-selectin recognizes fucosylated and sialylated ligands of 
the sialyl-Lewisx type. P-selectin recognizes the glycoproteins 
PSGL-1 on myeloid cells and TIM1 on activated T cells. L-selectin 
recognizes 6-sulfated carbohydrates expressed in high endothe-
lial venules and PSGL-1. Many macrophages express P-selectin, 
but its function in macrophages has not been studied. Monocytes 
express L-selectin, but its expression is lost upon differentiation 
to macrophages. L-selectin is an excellent example for an adhe-
sion molecule that is shed upon cell activation (83). Shedding of 
adhesion molecules, cytokine receptors, and pattern recognition 
receptors is an important mechanism that limits their signaling 
(84, 85). In some cases, the shed molecules can have signaling 
functions in their soluble form. The results in Figure 1F demon-
strate the expression levels of C-type lectins.
SCAveNGeR ReCePTORS
Scavenger receptors (Table 6)  are cell surface receptors that 
typically bind multiple ligands and promote the removal of non-
self or altered self targets. Both tissue-resident and monocyte-
derived macrophages express a number of scavenger receptors. 
They often function by mechanisms that include endocytosis, 
phagocytosis, adhesion, and signaling that ultimately lead to the 
elimination of degraded or harmful substances (7). Scavenger 
receptors recognize non-self (mostly bacterial products) and 
altered (oxidized, acetylated) self. They are more involved in 
TABLe 5 | C-type lectins.
Gene name C-type lectin CD Binds ligands from Function
Ly75 DEC-205 CD205 HIV, Yersinia pestis, E. coli; endogenous Uptake of pathogens and apoptotic cells
Clec10a Mgl1 CD301a Streptococci, Lactobacilli, apoptotic cells: Sialoadhesin Uptake of pathogens and apoptotic cells
Clec9a DNGR-1 F-actin Uptake of necrotic cells
Clec4e Mincle α-mannose and glycolipids from Mycobacterium tuberculosis, 
Candida albicans
Necrotic cell uptake; couples through FcRγ, 
activates NFkB
Clec7a BGR CD369 Beta-1,3-linked and beta-1,6-linked glucans from fungi and plants
Clec4a1 DCIR4 Unknown
Clec12a MICL CD371 Down regulated by cell activation
Clec4n Dectin-2-like
Clec4b1 DCAR Associates with Fc receptor γ chain
Clec4d MCL, MPCL CD368 Endocytotic, signals through Syk
Clec4a3 DCIR3
Clec4a4 DCIR2 Bisecting N-acetylglucosamine
Clec4k Langerin CD207 Measles virus
Cd209a DC-SIGN CD209 Microbial polysaccharides, sialylated antibody Possible role in Th17 response
Cd209b SIGNR1, CLEC4m CD209b Oligomannose Interacts with C1q
Cd209d SIGNR3 CD209d Leishmania, mycobacterial saccharides
Clec1b Clec2 High on platelets Required for lymphangiogenesis, separates 
lymphatics from blood vessels
Sell L-selectin CD62L High endothelial venules, PSGL-1 Rolling of Ly6Chi monocytes
Selp P-selectin CD62P PSGL-1, TIM1 Endothelial cells: rolling; macrophages: unknown
Sele E-selectin CD62E PSGL-1, CD44, CD43, others Largely restricted to endothelium
8
Ley et al. How Macrophages Sense What Is Going On
Frontiers in Immunology | www.frontiersin.org June 2016 | Volume 7 | Article 204
uptake and phagocytosis than activation of inflammatory effector 
systems. Scavenger receptors have recently been classified (53). 
The systematic names are SR followed by a letter (for the class) 
and numbers (for the members).
SR-A1, 2, and 3 and MARCO form the SR-A subfamily. 
Only SR-A1 has an SRCR domain and is the main macrophage 
receptor for HDL. MARCO is a collagen-like molecule; MARCO 
defects result in susceptibility to tuberculosis. The SR-B subfam-
ily comprises SR-B1 and SR-B2 (CD36). CD36 is an important 
receptor for diacyl glycerides, oxidized LDL, and the malaria 
parasites. CD36 is important for ROS and cytokine production 
by macrophages. There are no mammalian members of the SR-C 
subfamily. SR-D is CD68 (macrosialin), an intracellular recep-
tor of unknown function. SR-E1 is Lox1 (Loxin), which detects 
oxidized LDL. Dectin-1 is SR-E2. The mannose receptor MR is 
SR-E3 and the asialoglycoprotein receptor is SR-E4. SR-F1 is 
SCARF1, Ced1 in Caenorhabditis elegans, and SR-F2 is SCARF2. 
The only known SR-G is CXCL16, a receptor for oxidized LDL 
and a chemokine that binds CXCR6. SR-H1 is FEEL-1, also 
known as Stabilin-1 or Clever-1, SR-I is CD163, the macrophage 
receptor for hemoglobin–haptoglobin complexes. In bovine and 
ovine species, this subfamily has many more members. SR-J is 
RAGE, a seven-transmembrane receptor with multiple immu-
noglobulin domains that sees glycated proteins and advanced 
glycation end products. SR-L1 is also known as LRP1, and SR-L2 
as LRP-2.
Some macrophage scavenger receptors are currently unclas-
sified. Galectin-3-binding protein is a secreted product of 
M1 macrophages that binds galectin-3 and other cell surface 
ligands. CD207 (Langerin), MRC1 (CD206), CLEC7A, and 
CD209 (DC-SIGN) are also unclassified. CD206 is prominently 
expressed on M2 macrophages. C1q interacts with the Aβ protein 
relevant in Alzheimer’s disease. The results in Figure 1G show the 
expression levels of scavenger receptors.
CYTOKiNe ReCePTORS
Another class of macrophage receptors sense products of adap-
tive immune cells. These receptors can be considered secondary 
amplifiers, because they do not detect non-self or altered self, but 
rather amplify the macrophage response. Since most cytokines 
are produced by activated T cells that require antigen presenta-
tion and an ongoing immune response, the cytokine receptors on 
macrophages sense the nature of that ongoing immune response 
(Th1, Th2, Th17) (Table 7). 
IFN-γ receptor is a major activator of macrophages and 
reinforces the M1 phenotype (12). The Ifngr1 gene encoding this 
receptor is highly expressed in all macrophages. Its functional 
antagonist is IL4 receptor. Because of their important role in 
inflammation, we also discuss IL1 receptors, IL17 receptors, and 
IL27 receptor. A major anti-inflammatory pathway is initiated by 
TGF-β, which has three receptors.
IL4, 5, and 13 receptors promote and reinforce the M2 pheno-
type (3, 86, 87), but their ligation is not required for M2 polariza-
tion; in fact, it appears that M2 is the default “healing” phenotype 
TABLe 6 | Scavenger receptors.
Gene  
name
Systematic  
name
Other  
names
Ligands and function
Msr1 SR-A1 SCARA1
MSR1
Heat shock proteins, acLDL, oxLDL
Bacteria, yeast, amyloid, hepatitis C virus
Scara3 SR-A3 SCARA3
CSR
Protection from ROS 
Colec12 SR-A4 SCARA4
SRCL, COLEC12
Modified LDL
Endocytic receptor for lipoproteins 
Scara5 SR-A5 SCARA5 Binds bacteria
Marco SR-A6 MARCO Bacterial clearance from lung and blood
Scarb1 SR-B1 SCARB1 HDL
Cd36 SR-B2 CD36
Scarb3
Thrombospondin [modulates angiogenesis], foam cell formation in atherosclerosis by uptake of oxLDL, binds 
fungi, bacteria, Plasmodium falciparum-infected RBC interacts with TLR4 and TLR6, uptake of apoptotic cells
Scarb2 SR-B3 LIMP2 Delivers β-glucocerebrosidase from the endoplasmic reticulum to lysosomes, enterovirus 71 (EV71), 
coxsackievirus 7 (CVA7), CVA14, CVA16
Cd68 SR-D1 Macrosialin
CD68
Controversial: may bind oxidized lipoproteins, apoptotic cells, but inconsistent data
Olr1 SR-E1 LOX-1
OLR1
oxLDL, CRP
Clec7a SR-E2 Dectin-1 Bacterial, fungal, and plant carbohydrates β-glucans interacts with TLR2
Scarf1 SR-F1 SCARF1
SREC-I
Calreticulin, fungal and heat shock proteins, cross-presentation of antigens on MHC-I. Binds oxLDL. Apoptotic 
cell clearance
Scarf2 SR-F2 SREC-II
Megf10 SR-F3 MEGF10 Amyloid-β 
Cxcl16 SR-G1 RS-PSOX
CXCL16
oxLDL, phagocytosis of bacteria, chemotaxis through CXCR6
Stab1 SR-H1 Stabilin-1
FEEL-1
CLEVER-1
Lymphocyte adhesion, transmigration, angiogenesis, apoptotic cell clearance, and intracellular trafficking
Stab2 SR-H2 Stabilin-2
FEEL-2
Binds PS, interacts with GULP and thymosin-β4 to initiate uptake of apoptotic cells
Cd163 SR-I1 CD163 Hemoglobin-haptoglobin, anti-inflammatory signaling, secretion of cytokines IL-6 and IL-10
Ager SR-J1 RAGE Advanced glycation end products, high mobility group protein box 1, S-100, oxidative stress, pro-inflammatory
Lgals3bp Galectin-3 
binding protein
GAL3BP Binds galectin-1 and 3, anti-inflammatory, produced by M1 macrophages
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of macrophages (5). IL13 receptor α1 chain is expressed in all 
macrophages, but the α2 chain is missing from peritoneal mac-
rophages. IL5 receptor is expressed at very low levels on these 
cells.
TGF-β receptors strongly promote M2 polarization. TGF-β 
is made by many tissue cells, especially epithelial cells, and 
seems to signal to the macrophage that the tissue cells are in 
good health and not infected. Tgfbr1 is highly expressed in all 
macrophages, with highest levels in microglia. The same is true 
for Tgfbr2, but with highest levels in adipose tissue macrophages. 
Tgfbr3 is expressed in all macrophages except microglia and 
BMDM. Overabundance of TGF-β can lead to excessive collagen 
formation resulting in fibrosis. Macrophages have receptors for 
cytokines of the IL17 family. The results in Figure 1L indicate 
that the IL17 receptor A is expressed in all macrophages, and 
being highest in microglia. Il17rb, c, d, and e are expressed at 
low levels. IL1 receptors 1 and 2 are expressed at high levels in 
all macrophages.
TNF ReCePTOR SUPeRFAMiLY
The TNF receptor superfamily (Tnfrsf) (88–91) bind soluble 
and cell surface-expressed TNF superfamily members that have 
diverse biological functions (Table  8). These can range from 
molecules that induce caspase activation and apoptosis and 
regulate cell death (Fas, TNFRI, TRAILR) to those that activate 
NFκB and MAPK pathways and are pro-inflammatory (e.g., 
TNFRII, RANK, CD40, BAFFR, OX40) inducing a multitude of 
effects, such as promoting division, survival, cytokine produc-
tion, chemokine production, and upregulation of other receptors 
in varied protein families. The summarized expression values in 
Figure 1I reveal that the Tnfrsf receptors are of specific interest 
here, because many of them show highly differential expression 
among tissue macrophages, suggesting that different macrophage 
subsets have different abilities to see Tnfsf ligands.
Many of the Tnfrsf members are well known for controlling 
responses of T and B cells, dendritic cells, NK, and NKT cells, 
TABLe 7 | Cytokine receptors on macrophages.
Gene name Common name CD Ligands and function
Ifngr1 IFN-γ R IFN-γ: forces M1 polarization
Il1r1 IL-1 R1 CD121a IL-1α and β, pro-inflammatory
Il1r2 IL-1 R2 CD121b IL-1α and β, pro-inflammatory
Il4ra IL-4 R CD124 IL-4: forces M2 polarization
Il5ra IL-5 R CD125 IL-5: forces M2 polarization
Il10ra
Il10rb
IL-10Rα
IL-10Rβ
CD210 IL-10: strongly anti-
inflammatory, suppresses 
antigen presentation (135)
Il13a1 IL-13 R CD213a IL-13: forces M2 polarization
Il13a2 IL-13 R CD213b IL-13: forces M2 polarization
Il17ra IL-17RA CD217 IL-17a: activates 
macrophages
Il17rb IL-17RB Basophil function, asthma
Il17rc IL-17RC Needed for IL-17A-induced 
CXC chemokine expression
Il17rd IL-17RD Anti-inflammatory
Il17re IL-17RE Receptor for IL-17C: immunity 
to intestinal pathogens
Il27ra IL-27R IL-27: regulates Th1 and Treg
Tgfbr1 TGF-βR1 TGF-β: inactivates 
macrophages, determining 
receptor of microglia
Tgfbr2 TGF-βR2 TGF-β: inactivates 
macrophages
Tgfbr3 TGF-βR3 TGF-β: inactivates 
macrophages
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as well as inflammatory activity in structural cells, such as 
fibroblasts, epithelial cells, and osteoclasts. This has resulted in 
clinical targeting of many of the molecules for autoimmune and 
inflammatory diseases (89), and approved drugs in blockers of 
TNF and LTα binding to TNFRI and TNFRII for RA, psoriasis, 
Crohn’s disease, and others; blockers of RANKL binding to RANK 
for osteoporosis; and blockers of BAFF binding to its receptors 
BAFFR, TACI, and BCMA for SLE.
In macrophages, there appears to be strongly divergent expres-
sion among tissue macrophages (Figure  1I). Tnfrsf1a (TNFR1), 
Tnfrsf1b (TNFR2), Tnfrsf11a (RANK), and Tnfrsf3 (LTβR) are 
highly expressed by most tissue macrophages. Tnfrsf5 (CD40), 
Tnfrsf12a (Fn14), Tnfrsf14 (HVEM), Tnfrsf21 (DR6) are also 
highly expressed in some macrophage populations, but variably 
expressed in others at moderate levels. TNFR2 is largely pro-
inflammatory, whereas TNFR1 can display both pro-inflammatory 
and anti-inflammatory (apoptosis-inducing) activities. Since TNF 
is a product of macrophages, various reports have suggested both 
positive and negative effects of TNF on macrophages correlating 
with these functions of its receptors (92–96). The outcome of TNFR 
signaling in macrophages may be heavily influenced by the loca-
tion of the cells and the inflammatory environment in which they 
are responding. CD40, RANK, and LTβR are stimulatory receptors 
for antigen-presenting cells, particularly dendritic cells and B cells. 
CD40 is best known in this regard, but RANK and LTβR can display 
overlapping and synergistic activities. They have been less studied 
in macrophages, but parallel activities in promoting survival, 
differentiation, and inflammatory cytokine production, as well as 
upregulating co-stimulatory ligands that promote T cell activation, 
are consequences of engaging these receptors (97, 98). However, 
some studies of LTβR signaling on macrophages have suggested 
a regulatory activity in limiting TLR signaling (99). HVEM 
shares binding to the ligand LIGHT with LTβR. Signaling from 
either HVEM or LTβR can promote migration of macrophages 
(98, 100) and can induce inflammatory mediators, such as TNF, 
IL8, MMPs, and TGF-β (101, 102). Fn14 has been implicated in 
driving  inflammation and remodeling activities in several tissues. 
TWEAK, the ligand for Fn14, can be made by macrophages (103) 
and TWEAK can also exert pro-inflammatory activity in mac-
rophages via Fn14, promoting production of molecules, such as 
IL6, IL8, MCP-1, MMPs, and HMGB1, and driving macrophage 
migration into inflamed sites (104–107).
The receptors for BAFF and APRIL are best known as regula-
tors of B cell survival or differentiation and also control T cell 
activity in some cases. Tnfrsf13c (BAFFR) that only binds BAFF 
was low in all macrophages, but Tnfrsf13b (TACI) and Tnfrsf17 
(BCMA) that bind BAFF and APRIL were high in intestinal, adi-
pose, and peritoneal macrophages and adipose macrophages and 
microglia, respectively. BAFF can be made by macrophages in 
soluble and membrane form, and membrane BAFF may (reverse) 
signal to promote inflammatory mediators (108), but the roles 
of the receptors are not well understood. Recent studies suggest 
that TACI or BCMA signals can also promote pro-inflammatory 
cytokines/mediators (109). TACI activity may also suppress 
differentiation of macrophages into the M2 phenotype, allowing 
enhanced clearance of intracellular organisms (110).
Tnfrsf9 (4-1BB), Tnfrsf25 (DR3), Tnfrsf4 (OX40), Tnfrsf18 
(GITR), Tnfrsf8 (CD30), and Tnfrsf7 (CD27) showed low levels 
of transcript expression in most tissue macrophages, as did 
the decoy receptor for RANK (Tnfrsf11b – OPG). 4-1BB, DR3, 
OX40, GITR, CD30, and CD27 are best known as regulators of 
conventional T cells as well as Treg cells, NK, or NKT cells. Most 
have rarely been found on the surface of macrophages, although 
several studies have seen DR3 and GITR on macrophages/foam 
cells associated with atherosclerotic plaques, or in joints associ-
ated with RA (111–114). Signaling through these receptors, 
probably via NFkB, may aid production of pro-inflammatory 
molecules, such as TNF or MMPs. The ligands for 4-1BB, DR3, 
OX40, GITR, and CD27 can be expressed by many macrophages 
after they are activated, and can aid the antigen-presenting 
capacity of macrophages by providing co-stimulatory signals 
to their receptors on T cells. Certain TNF family ligands, like 
4-1BBL, TL1A (ligand for DR3), and GITRL can also signal into 
macrophages or monocytes (reverse signaling) to modulate their 
survival, production of cytokines or molecules, such as PGE2, 
COX-2, and iNOS, and in some cases migration (115–119). In the 
case of 4-1BBL, it can also associate with TLRs on macrophages 
independently of binding its receptor and enhance TLR signal-
ing (120, 121).
Tnfrsf27 (EDA2R) was low/absent in most macrophages, not 
surprising given its role outside the immune system in formation 
of tissues, such as sweat glands. Tnfrsf19 (TROY) is primarily 
expressed in the nervous system and has been suggested to 
regulate axon regeneration, but may also contribute to hair fol-
licle formation. TROY was also low in most tissue macrophages 
and BMDMs. One prior report had suggested that it could be 
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expressed in microglia in MS patients (122) but this has not been 
confirmed.
The death receptors Tnfrsf10b (TRAILR2) and Tnfrsf6 
(Fas), and the mouse decoy receptors for TRAIL (Tnfrsf22 and 
23 – mDcTRAILR1 and R2) showed low levels of expression in 
most macrophages, except for Fas in peritoneal macrophages 
and mDcTRAILR1 in BMDM, lung, liver, and peritoneal cells. 
Fas is likely to promote apoptosis of macrophages in some 
cases to limit autoimmunity or inflammation (123, 124), but 
it can be pro-inflammatory by augmenting caspase-dependent 
production of IL1 and IL18 or other activities (125–127). It is 
not known when production of the TRAIL decoy receptor by 
macrophages could be important for limiting TRAILR activity. 
Tnfrsf21 (DR6) is another death receptor that has been reported 
to regulate neuronal death and may also limit T and B cell activa-
tion, but whether it has other functions is not clear. It was highly 
expressed in microglia, peritoneal, spleen, and lung macrophages 
and BMDM (Figure 1I).
Fc ReCePTORS
Fc receptors (Table 9) are receptors for immunoglobulins, which 
are products of plasma cells, and immune complexes. There are 
receptors for IgG (FcγRI, II, and III) (128, 129) and IgE (Fce 
receptor). They vary in their affinity (high to low) and in their 
downstream signaling effects (activating and inhibitory). Fc 
receptors are very highly expressed and are of key importance for 
clearing antibody-opsonized pathogens and antibody-opsonized 
necrotic cells. In the mouse, most Fc receptors signal through 
a common adaptor protein called Fc receptor γ chain or CD23.
The results in Figure 1J summarize the expression of Fc recep-
tors in tissue macrophages. Fcgr1, the gene encoding the CD64 Fc 
TABLe 8 | TNF receptor superfamily.
Gene name Systematic name Other names Ligands and function
Tnfrsf1a Tnfrsf1a TNFR1 TNF, soluble lymphotoxin α: pro- and anti-inflammatory (apoptosis) many cell types
Tnfrsf1b Tnfrsf1b TNFR2 TNF, soluble lymphotoxin α: pro-inflammatory many cells; T cell activation
Ltbr Tnfrsf3 LTβR Membrane lymphotoxin β and LIGHT: pro-inflammatory for APC and tissue cells; lymph node development
Tnfrsf4 Tnfrsf4 OX40, CD134 OX40L (=CD252): T and NK activation/differentiation
Cd40 Tnfrsf5 CD40 CD40L (=CD154): immunoglobulin class switching, APC activation
Fas Tnfrsf6 Fas
CD95
FasL (=CD178): apoptosis/cell death
Cd27 Tnfrsf7 CD27 CD70: T and B cell activation; antibody production
Tnfrsf8 Tnfrsf8 CD30 CD30L (=CD153): T and B cell activation
Tnfrsf9 Tnfrsf9 4-1BB, CD137 4-1BBL: T and NK activation/differentiation
Tnfrsf10b Tnfrsf10b TRAIL R2
DR5 CD262
TRAIL (=CD253): apoptosis in tumor cells and T cells 
Tnfrsf11a Tnfrsf11a RANK
CD265
RANKL (=CD254): osteoclast and lymph node development; activation of APC. Blockers of RANKL (antibody: 
denosumab) binding to RANK are used clinically to treat osteoporosis
Tnfrsf11b Tnfrsf11b OPG Decoy receptor for RANK: modulates osteoclastogenesis
Tnfrsf12a Tnfrsf12a Fn14
CD266
TWEAK: tissue inflammation 
Tnfrsf13b Tnfrsf13b TACI, CD267 APRIL (= CD256) and BAFF (= CD257): B cell activation/differentiation
Tnfrsf13c Tnfrsf13c BAFFR
CD268
BAFF (= CD257): B cell differentiation/survival. Blockers of BAFF (antibody: belimumab) binding to its receptors 
BAFFR, TACI, and BCMA are used clinically to treat systemic lupus.
Tnfrsf14 Tnfrsf14 HVEM
CD270
LIGHT (= CD258): T cell activation; pro-inflammatory tissue cells and APC; BTLA: T cell inhibition
Tnfrsf17 Tnfrsf17 BCMA
CD269
APRIL (= CD256) and BAFF (= CD257): B cell activation/differentiation
Tnfrsf18 Tnfrsf18 GITR
CD357
GITRL: T and B cell activation
Tnfrsf19 Tnfrsf19 TROY Nogo coreceptor: axon regeneration?
Unknown: hair follicle development?
Tnfrsf21 Tnfrsf21 DR6
CD358
Amyloid precursor protein: neuron death?
Unknown: T cell inhibition/death
Tnfrsf22
Tnfrsf23
Tnfrsf22 and 23 mDcTRAIL R2 
and mDcTRAILR1
Decoy receptors for TRAIL only expressed in mice: neutralize TRAIL activity
Tnfrsf25 Tnfrsf25 DR3 TL1A: T cell activation/differentiation
Eda2r Tnfrsf27 XEDAR
EDA2R
EDA: control of hair follicle, sweat gland, teeth development
TABLe 10 | GPCRs expressed on macrophages.
Gene name GPCR CD, other Function
Ccr1 CCR1 CD191 Pro-inflammatory
Ccr2 CCR2 CD192 Recruits monocytes
Ccr5 CCR5 CD195 Arrest, integrin activation, 
recruits monocytes
Ccr7 CCR7 CD197 Directs macrophages and 
dendritic cells to lymphatics 
and lymph nodes, also 
involved in lymphocyte 
homing and development
Cx3cr1 CX3CR1 Fractalkine R: Macrophage 
survival
Adora1 Adenosine A1 Pro-inflammatory, 
sleep-inducing
Adora2a Adenosine A2a Anti-inflammatory. 
Istradefylline is an A2A 
antagonist approved for 
Parkinson’s disease
Adora2b Adenosine A2b Pro-inflammatory
Adora3 Adenosine A3
P2ry1 ATP R 1 ATP and ADP receptor
P2ry2 ATP R 2 Apoptotic cell recognition
P2ry12 ATP R 12 ATP and ADP receptor
S1pr1 S1P1 CD363 Regulates lymphocyte 
trafficking
S1pr2 S1P2 EDG5
S1pr3 S1P3 EDG3
S1pr4 S1P4 EDG6
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γ receptor, is specific for macrophages and has been proposed as 
a universal mouse macrophage marker (40).
CHeMOKiNe ReCePTORS  
AND OTHeR GPCRs
Macrophages and dendritic cells are important sources of 
many inflammatory chemokines including CCL1, 2, 3, 4, and 
5. However, they also express chemokine receptors (Table 10) 
and, thus, respond to their chemokine environment. The major 
chemokine receptors on macrophages are CCR2, CCR5, and 
CX3CR1 (130, 131). CCR2 binds CCL2 and related chemokines 
of the MCP subfamily and is responsible for release of mono-
cytes from the bone marrow and their trafficking to inflamed 
tissues. CCR1 and 2 are expressed in all tissue macrophages, 
but very low in microglia. CCR5 is a receptor for CCL5 and 
attracts monocytes to the vascular wall. It is expressed in all 
macrophages, highest in microglia. CX3CR1 is a receptor for 
CX3CL1 (fractalkine) and promotes macrophage survival. It is 
expressed in all macrophages, highest in microglia and intesti-
nal macrophages.
OTHeR GPCRs
Other GPCRs (Table 10) include four adenosine receptors, Adora 
1, 2a, 2b, and 3. Adenosine is a ubiquitous metabolite found in 
the extracellular space, and macrophages can respond to adeno-
sine through these receptors. ATP is released by apoptotic cells 
through a pannexin-dependent mechanism, and ATP and ADP 
are important metabolites influencing macrophages through 
P2Y receptors. Sphingosine-1-phosphate is produced by platelets 
and other blood cells and is sensed by macrophages through S1P 
receptors S1P1-4 (Figure 1K).
The adenosine receptor A2A (Adora2a) is expressed at low 
levels in all tissue macrophages except microglia. This recep-
tor downregulates inflammatory responses. A2B (Adora2b) 
is also expressed at low levels, but much higher in adipose 
tissue macrophages. This is considered a pro-inflammatory 
receptor.
P2Y1 (P2ry1) is an ADP receptor with low expression in all 
macrophages except microglia, where it does not appear to be 
expressed. By contrast, the ADP receptor P2Y12 (P2ry12) shows 
low expression in all macrophages but very high expression in 
TABLe 9 | Fc receptors.
Gene name FcR CD Function
Fcgr1 FcRγI CD64 High affinity IgG binding
Fcgr2b FcRγIIb CD32 Low affinity IgG R, immune complexes
Fcgr3 FcRγIII CD16 Low affinity IgG R, immune complexes
Fcgr4 FcRγIII-2 CD16-2 Low affinity IgG R, immune complexes
Fcer1a FceR High affinity IgE receptor
Fcer1g Fc γ chain CD23 Adaptor for most Fc receptors
Fcer2a FcreR2 CD23a Low affinity IgE receptor
Ms4a2 Fcer1b
microglia. P2Y12 on platelets is a target for anti-thrombotic treat-
ment. P2Y2 is a receptor for UTP and ATP, which is released from 
apoptotic cells via pannexin (PANX1) (132).
The sphigosine-1-phosphate receptor encoded by S1pr1 
is expressed by all tissue macrophages. S1pr2 is also broadly 
expressed, with highest levels in BMDM and bone marrow mac-
rophages. S1pr3 and S1pr4 are expressed at low levels. Expression 
of these GPCRs is shown in Figure 1K.
iNTeGRiNS
Macrophages use integrins (Table 11), αβ heterodimers that bind 
to extracellular matrix molecules (ECM) and other cells (133, 
134). Since integrins, once bound to ligand, promote outside-in 
signaling, integrin engagement is an important input into mac-
rophage biology. Almost all integrin subunits are expressed at 
some level in various tissue macrophages.
Many integrin α subunits pair with β1, which is expressed in 
all macrophages (Itgb1). Itga1, Itga11, Itga2, Itga2b, Itga3, and 
Itga7 are expressed at low levels. Itga4 pairs with Itgb1 forming 
VLA-4, an integrin known to be involved in monocyte recruit-
ment to tissues. Itga4 expression varies widely between tissue 
macrophages, with highest expression levels seen in large and 
small peritoneal macrophages. Itga5 pairs with Itgb1 to form a 
fibronectin receptor that is expressed at moderate levels in all 
tissue macrophages, highest in thioglycollate-elicited peritoneal 
TABLe 11 | integrins.
Gene  
Name
integrin CD, other Function
Itgb1 β1 integrins CD29 Pairs with α1–11
Itga1 α1β1 CD49a Collagen receptor
Itga3 α3β1 CD49c Type 4 collagen receptor
Itga4 α4β1 CD49d Binds VCAM-1 and 
alternatively spliced fibronectinVLA-4
Itga5 α5β1 CD49e Bind fibronectin, pro-
inflammatory signalVLA-5
Itga6 α6β1 CD49f Laminin binding
VLA-6
Itga7 α7β1 Muscle development
Itga8 α8β1 Extracellular matrix assembly?
Itga9 α9β1 Fertilization of egg
Itga10 α10β1 Collagen binding
Itga11 α11β1 Collagen binding
Itgb2 β2 integrins CD18 Pairs with αL, αM, αX, αd
Itgal αLβ2 CD11a/CD18
LFA-1
Adhesion to ICAM-1, 2, and 3
Itgam αMβ2 CD11b/CD18
Mac-1
Binds C3bi, ICAM-1, 
denatured proteins, and many 
other ligands
Itgax αXβ2 CD11c/CD18 Binds C3bi, ICAM-1, 
denatured proteins
Itgad
Itgb3
αDβ2
β3 integrins
CD11d/CD18
CD61
Binds ICAM-3
Itga2b αIIbβ3 CD41/CD61 High on platelets, binds 
fibrinogen
Itgav αVβ3 CD51/CD61 Major receptor for vitronectin, 
uptake of apoptotic cells
Itgb6 αVβ6 CD51 Involved in TGFβ activation 
(136)
Itgb7 β7 integrins Ly69 Intestinal specific
Itga4 α4β7 CD49d
LPAM
Binds MAdCAM-1
Itgae αEβ7 CD103 Binds to E-cadherin
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macrophages. Itga6/Itgb1 encodes a laminin receptor that is 
highly expressed in peritoneal macrophages and microglia, 
but lower in liver, spleen, and adipose tissue macrophages. 
Itga8 is expressed in all tissue macrophages except peritoneal. 
Itga9 and 10 are expressed at intermediate to high levels in all 
macrophages.
The integrin subunits Itgal, Itgam, Itgax, and Itgad all pair 
with Itgb2 and are leukocyte specific. These β2 integrins are 
highly expressed in all macrophages, with highest mRNA levels 
in thioglycollate-elicited peritoneal macrophages. Itgal (LFA-1) 
is expressed at modest levels in most macrophages but not in 
microglia. Itgam (Mac-1), also known as complement receptor-3, 
is expressed at intermediate levels in most macrophages but very 
high in peritoneal and BMDM. Itgax (CD11c) is widely used as 
a dendritic cell marker, but this integrin is also expressed in all 
macrophages, most highly in thioglycollate-elicited peritoneal 
macrophages. Itgad (CD11d) is expressed at very low levels except 
for spleen macrophages, where it is very high.
Itgav pairs with Itgb3 to form the vitronectin receptor αVβ3, 
also known as leukocyte response integrin. Both subunits are 
expressed across all macrophages. Itgav can also pair with Itgb6 to 
form αVβ6 integrin, which is involved in TGF-β processing and 
fibrosis. Itgae and Itga4 pair with Itgb7, a receptor family gener-
ally found more in intestinal tissues. Indeed, Itgb7 expression is 
highest in peritoneal and intestinal macrophages. Itgae is highly 
specialized and binds to E-cadherin. Its expression is low except 
in intestinal macrophages, where it is very high (Figure 1H). The 
collagen receptor α2β1 integrin was not expressed in any of the 
macrophages studied here.
CONCLUDiNG ReMARKS
This review provides a broad overview of receptors used by mac-
rophages to sense their environment, including apoptotic and 
necrotic cells, pathogens, carbohydrates, modified self molecules, 
cytokines, chemokines, and other soluble molecules and extracel-
lular matrix components. Some of these macrophage receptors are 
broadly expressed in all tissue macrophages studied, while others 
are highly restricted. This suggests that certain macrophages 
are well equipped for certain functions (listed in the tables) and 
others are “blind” to certain challenges or inputs. Recent reviews 
on each of the 12 classes of receptors are cited in the respective 
subsections for more detailed information. The remarkable het-
erogeneity in expression of macrophage receptors suggests highly 
specialized functions of resting tissue macrophages in lung, liver, 
spleen, intestine, fat tissue, the peritoneal cavity, and the brain 
(microglia).
This review is limited to mRNA expression data, and it is 
unknown how these expression patterns correlate with protein 
levels. In macrophages, the correlation between mRNA and 
protein levels is modest. Also, we consider the 12 receptor classes 
individually, but they may cooperate or even compete for ligand 
recognition, which would affect macrophage function. There 
could be more than one “danger” that affects a tissue, such as 
infection with multiple pathogens or viral infection and apoptotic 
cells. How tissue macrophages respond to such complex inputs 
remains to be studied. We did not analyze infiltrating monocyte-
derived macrophages here, which can be a dominant population 
in inflammatory diseases, infections, autoimmune diseases, and 
cancer.
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